Prevention of Pressure Ulcers in Patients at Medium to High Risk of Developing Pressure Ulcers and Using the DOMUS 4 / AUTO Motorized Air Mattress
1 other identifier
observational
86
1 country
5
Brief Summary
The aim of the study is to determine the clinical value of using a powered alternating pressure air mattress (P-APAM) in the prevention of pressure injury (PI) in patients at medium to high risk. This study is noncomparative, observational study. Patients older than 18 years of age, with a medium to high risk of PI, without PI, up during the day, and lying more than 15 hours a day on a specific P-APAM were included. The study was conducted in nursing homes, and in long-stay geriatrics department. Patients are followed up for 35 days. The use of the P-APAM is associated with the usual PI prevention measures. The primary outcome is the percentage of patients who developed between day 0 and day 35 at least one PI of at least stage 2 on the sacrum, spine, or heel. Secondary endpoints are patient assessments of comfort, caregiver satisfaction, mattress noise level, and mattress safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2018
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2019
CompletedFirst Submitted
Initial submission to the registry
July 21, 2022
CompletedFirst Posted
Study publicly available on registry
July 25, 2022
CompletedJuly 26, 2022
July 1, 2022
10 months
July 21, 2022
July 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of patients who developed at least one stage 2 pressure injury
Percentage of patients who developed at least one stage 2 PI of the sacrum, backbone, or heel (areas of support when lying down)
35 days after installation on the mattress (at day 35)
Secondary Outcomes (5)
Percentage of patients who developed a o pressure injury (any stage), other than those of the sacrum, backbone, or heel between
35 days after installation on the mattress (at day 35)
Assessment by the patient (or family or staff in the case of incapacity) of the comfort of the mattress (general comfort, stability)
35 days after installation on the mattress (at day 35)
Assessment by the nursing staff with the use of the mattress (implementation, cleaning maintenance turning, changing to a sitting position)
35 days after installation on the mattress (at day 35)
Assessment of the degree of maceration
35 days after installation on the mattress (at day 35)
Assessment of mattress safety
At day 35
Interventions
Patients with a medium to high risk of pressure injury, without pressure injury, up during the day, will ly a on a specific P-APAM (DOMUS 4 /AUTO)
Eligibility Criteria
Patients in nursing homes or long-stay geriatrics department
You may qualify if:
- Patient over 18 years old
- Patient with a medium to high risk of developing pressure ulcers (clinical judgment and a score of \[10 to 14\] on the Braden scale (6 (maximum risk) to 23 (no risk))
- Patient up during the day, lying between 3 p.m. and 8 p.m. a day on a Domus 4 / AUTO mattress
- Patient with a weight \< 200 kg
- Patient (or a trusted third party) having been informed of the study and agreeing to participate
You may not qualify if:
- Patient at end of life (estimated life expectancy less than 6 months)
- Malnourished patient according to the french health authority (Haute Autorité de la santé) definition\*
- \* For adults under 70:
- weight loss ≥ 5% in one month or ≥ 10% in six months
- or body mass index (BMI) ≤ 18.5 (excluding constitutional thinness)
- for adults over 70:
- weight loss ≥ 5% in one month or ≥ 10% in six months
- or BMI ≤ 21
- or Mini Nutritional Assessment (MNA) ≤ 17 (/30)
- or albuminemia \< 35 g/L
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wellell Francelead
- Clin-Expertscollaborator
Study Sites (5)
Ehpad Du Parc Chateau D'Abondant
Abondant, France
Ehpad Esbv
Baugé-en-Anjou, France
Ehpad Residence Le Parc
Fontenay-aux-Roses, France
Ehpad Duc de Lorge
Saint-Jean-d'Illac, France
Ehpad Villa Du Tertre
Saint-Parres-aux-Tertres, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvie MEAUME, Pr
Hôpital ROTSCHILD
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2022
First Posted
July 25, 2022
Study Start
September 17, 2018
Primary Completion
July 22, 2019
Study Completion
July 22, 2019
Last Updated
July 26, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share